The pharmaceutical industry is constantly looking for ways to cut costs, speed drugs to market and develop innovative new products to improve patient care. Biomarker technology can help your company achieve these three key goals. Yet despite the benefi ts biomarker technology has the potential to accrue, it is not yet widely applied. Successful application could give your company the competitive advantage it seeks, and this conference will help identify areas where biomarkers can be implemented in your business practices.
Biomarker technology can facilitate earlier identifi cation of successful candidate molecules, allowing go/no-go decisions to be taken sooner
and for resources to be allocated more effi ciently and effectively. They are also crucial for keeping up with the changing nature of the pharmaceutical market. As the traditional blockbuster business model falters in its tracks, recently illustrated by Pfi zer’s diffi culties with Exubera, it seems the industry is shifting towards portfolios of personalised medicines. These can only be developed with the aid of biomarkers.
It is a new and exciting technology, which still has a lot of scope for innovative business applications. Methods of discovery are constantly evolving; as scientists begin to fully understand the potential of genomics, the whole scope of proteome analysis opens up before them. Applications for these new discoveries are still being explored and a major challenge is now faced in convincing the regulators.
This three day Visiongain conference will explore the business applications and regulatory considerations necessary for you to realise the potential biomarkers have for your business.
Reasons you cannot afford to miss this event:
Identify areas where biomarker technology can increase the effi ciency of your clinical trial process.
Understand the potential for biomarkers in developing personalised medicine. How will this change the existing big pharma business model? Prepare your business to more fully integrate these operational and organisational changes.
Discuss the latest biomarker assay developments and methods of clinical validation.
Gain a deeper understanding of the growing biomarker industry. Who are the key players? What are the next developments?
Register now to keep your business at the cutting edge of technological advances.
I look forward to meeting you at the conference
Best regards
Sara Feast
Conference Producer
Pharmaceutical Division
For more information kindly visit: http://www.bharatbook.com/
